fbpx

Phase II Trial of the electrocutaneous nerve stimulation device, MC5-A Calmare. In patiens with refractory chemotherapy induced peripheral neuropathy

2.3 MEETING ASCO 2010 – Poster

Phase II Trial of the electrocutaneous nerve stimulation device, MC5-A Calmare. In patiens with refractory chemotherapy induced peripheral neuropathy

Thomas J. Smith, Patrick J. Coyne, Patricia A. Dodson, Gwendolyn Parker, V. Ramakrishman
Virginia CommoNwealth University Massey Cancer Center

Lascia una recensione

avatar
  Subscribe  
Notificami